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Abstract 
Objective: This study aimed to evaluate the usefulness of the subtraction method for 
improving sentinel lymph node (SLN) visibility by reducing scattering near the 
injection site. 
Methods: Images of two phantoms for the injection site and SLNs built using an 
original design were simultaneously acquired using a dual-head camera equipped with a 
low-energy high-resolution (LEHR) on the lower detector (posterior view) and a 
low-energy general-purpose (LEGP) collimator on the upper detector (anterior view). 
Subtraction method images were created by subtracting the posterior view from the 
anterior view, the latter of which was designated as the conventional method. Image 
contrast was calculated from the counts of regions of interest (ROI) placed on the two 
phantoms of the injection site and SLNs. SLNs visibility to a distance from the injection 
site and a radioactivity ratio based on the injection site (15 MBq) was evaluated by 
image contrast and visual interpretation. 
Results: The best improvement in contrast occurred at a distance of 20 pixels (1.08 
mm/pixel) from the injection site, and improved further as the lymph node radioactivity 
is smaller. The SLNs visibility corresponding to a distance of 20 pixels improved 
significantly (p < 0.001), from 1/2560 of radioactivity at the injection site 
(approximately 6 kBq) to 1/640 (approximately 23 kBq), and SLN was only detectable 
using the subtraction method. SLN (1/5120, approximately 3 kBq) was difficult to 
detect even with the subtraction method, whereas SLN with a ratio ≥1/320 
(approximately 46 kBq) was easily detected even with the conventional method. These 
visibilities did not differ significantly between the two methods (p = 0.16 and >0.32, 
respectively). The subtraction method could detect SLNs near the tumor on clinical 
images. 
Conclusions: The subtraction method improved SLN visibility near the injection site 
by reducing scattering from the injection site. Furthermore, an advantage of the 
subtraction method is that it does not require additional imaging because the posterior 
view is obtained simultaneously and utilized. 
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INTRODUCTION 
The presence of cancer cells in the sentinel lymph node (SLN) is an important factor 
used in cancer staging [1]. Most facilities use preoperative lymphoscintigraphy to 
localize SLNs in patients with breast cancer. In breast cancer cases, lymphoscintigraphy 
reveals drainage from the tumor to axillary lymph nodes and accurately localizes SLNs 
within the body, thus providing surgical assistance [2-6]. Currently, lymphoscintigraphy 
is the standard means of evaluating SLNs from tumors. 
There are some disadvantages to lymphoscintigraphy. For example, a large amount of 
radioactivity is retained at the injection site; however, the target SLN is small in size 
and retains only a small amount of radioactivity [4]. Therefore, radioactive scattering 
may cover SLNs near the injection site on images. 
To address this disadvantage, multiple methods [7-18] have been developed to 
minimize the effects of scattering and to improve SLN visibility during 
lymphoscintigraphy imaging. However, the use of these methods requires a new 
imaging in addition to as the usual imaging. 
We devised a subtraction method that utilizes a posterior view acquired through 
simultaneous imaging, thus eliminating the requirement for additional imaging. We 
subsequently verified the effectiveness of this subtraction method for improving SLN 
visibility of breast cancer by evaluating two phantoms constructed based on clinical 
data. 
 
MATERIALS AND METHODS 
Original phantoms 
We constructed two original phantoms to evaluate the subtraction method.  
The first was a combination (CB) phantom (CB phantom) that imitated the injection 
site and SLNs. The sources in the CB phantom that imitated the injection site and SLNs 
are hereafter referred to as CBIS and CBLN, respectively. CBIS measured 20 mm in 
diameter and contained 15 MBq of 99mTc-pertechnetate. The CBLNs each measured 10 
mm in diameter and contained either 29 kBq (low count) or 58 kBq (high count) of 
99mTc-pertechnetate. 
The second was a multi-lymph node phantom (MT phantom) intended to imitate 
SLNs with various levels of radioactivity. The source in the MT phantom that imitated 
SLNs is hereafter referred to as MTLN. The 10 MTLNs each measured 10 mm in 
diameter. The 99mTc-pertechnetate radioactivity levels ranged from 1/10 (approximately 
1.5 MBq) to 1/5120 (approximately 3 kBq) of the CBIS radioactivity through a 10-step 
1:1 serial dilution. 
In the phantoms, small containers with plastic caps were used to imitate the injection 
site and SLNs and were fixed on an acrylic board. Figure 1a and 1b show the source 
layout and radioactivities of the CB and MT phantoms. These phantoms were placed 
between models intended to imitate the human body, as shown in Figure 1c. The 
thicknesses of these models were categorized as obesity, normal, and leptosome to 
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elucidate the effects of attenuation in the posterior view on various body types. The 
thicknesses were determined based on a random sampling of chest computed 
tomography (CT) images of 50 patients. Since chest CT images are routine image, it 
was conducted in accordance with the comprehensive prior consent and it was approved 
by the institutional ethics committee of our institution. Table 1 shows the thickness and 
material of each model. 
 
 
Figure 1: Source layout of the two phantoms and the phantom disposition diagram 
during imaging. (a) For the combination (CB) phantom, the CB phantom injection site 
(CBIS; center) is 20 mm in diameter and contains 15 MBq of 99mTc-pertechnetate. CB 
phantom lymph nodes (CBLNs; both sides) are 10 mm in diameter and comprise 4 
pieces each in horizontal direction at intervals of 10 mm from the periphery of CBIS. 
The sources contain 29 kBq (right side) and 58 kBq (left side) of 99mTc-pertechnetate. 
(b) For the multi-lymph node (MT) phantom, the MT phantom lymph nodes (MTLNs) 
are 10 mm in diameter. The 99mTc-pertechnetate radioactivities in the MTLNs ranged 
from 1/10 (approximately 1.5 MBq) to 1/5120 (approximately 3 kBq) based on the 
radioactivity of CBIS through a 10-step 1:1 serial dilution. These MTLNs were ordered 
from top left to top right and bottom left to bottom right. (c) Regarding the disposition 
of each phantom model, each part is composed of a breast surface (gray), either of the 
CB phantom or of the MT phantom (black), breast (gray), lung field (light gray), and 
soft dorsal tissue (gray), as shown from above. The thickness of each model was 
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Table 1: Thicknesses of phantom components for each body type. 
Leptosome Normal Obesity
Surface of breast Water equivalent phantom 10 10 10
Breast (soft tissue) Water equivalent phantom 10 25 50
Lung field Sponge 90 110 130
Soft tissue of back Water equivalent phantom 10 25 40
Phantom parts Materials




Phantoms were imaged with a dual-head γ-camera (GCA7200A/UI; Toshiba Medical 
Systems Corp., Otawara, Japan). The collimators were equipped with a low-energy 
high-resolution (LEHR) on the lower detector (posterior view) and low-energy 
general-purpose (LEGP) on the upper detector (anterior view). Although it is irregular 
to acquire scintigrams by using a dual-head gamma camera equipped with different 
kinds of collimators, we have obtained lymphoscintigraphy by using this unique method 
in the daily clinical practice for more than 10 years and we have interpreted these 
lymphoscintigrams based on our own responsibility. Despite the 10 kg difference in 
weight between the two collimators, the manufacturers confirmed that imaging with 
different collimators would not present a safety issue.  
Static images with a matrix of 512 × 512 (1.08 mm/pixel) were simultaneously 
acquired for 5 minutes. The original image of anterior view alone was considered the 
conventional method image in this study. 
 
Procedure for creating the subtraction method image 
The posterior view was subjected to horizontal inversion processing. Afterwards, we 
corrected a gap caused by a geometrical γ-camera error present between the upper and 
lower detectors. This gap measured 2 pixels in the horizontal axis direction with this 
camera. Lastly, the processed posterior view was simply subtracted from the anterior 
view without requiring the incorporation of a coefficient. As shown in Figure 2, (a, d, 
and g) left column is anterior (original) images, (b, e, and h) central column is the 
processed posterior view for subtraction method, and (c, f, and i) right column is images 
of the subtraction method. A series of this operation was performed using an image 
processing system attached to the γ-camera (GMS5500A/UI; Toshiba Medical Systems 
Corp.). 
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Figure 2: Images and profile curves obtained with the combination (CB) phantom. The 
upper row shows (a) the conventional method, (b) posterior image of the low-energy 
high-resolution (LEHR) collimator after horizontal inversion for subtraction, and (c) 
subtraction method on a leptosome body type model. The middle row shows (d) the 
conventional method, (e) posterior image of the LEHR after horizontal inversion for 
subtraction, and (f) the subtraction method on a normal body type model. The lower row 
shows (g) the conventional method, (h) posterior image of the LEHR after horizontal 
inversion for subtraction, and (i) the subtraction method for an obesity body type model. 
 
Data analysis 
We evaluated the following 4 items to verify the usefulness of the subtraction 
method: Effect of scattering emitted from CBIS, deterioration of visibility due to 
subtraction processing, image contrast, and visual evaluation. 
Regarding the effect of scattering emitted from CBIS, CBLN visibility was evaluated 
from the CB phantom image and profile curve. The profile curve was drawn as a 
continuous plot of counts of regions of interests (ROIs) in the CB phantom. The ROIs 
measured 10 pixels in width and were measured in the horizontal axis direction, thus 
incorporating both CBIS and CBLNs. 
With respect to the deterioration of visibility caused by subtraction processing, we 
evaluated whether the subtraction method would deteriorate MTLN visibility relative to 
the conventional method with regard to the count ratio. The count was obtained from 
the value of each 5 × 5-pixel ROI placed on the centers of the MTLNs. 
In regard to image contrast, we compared this parameter in MTLNs using values 
calculated from the scattering count emitted from CBIS and MTLNs counts because the 
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phantom image could not discriminate the true SLN count and the background count. 
Contrast was calculated using the following equation:  
C = (SLN-BG) / (SLN+BG): (Eq. 1),  
where C represents contrast, SLN represents the mean count in MTLN ROIs, and BG 
represents the mean count in scattering ROIs from CBIS. We determined the BG by 
placing 5 × 5-pixel ROIs from 10 pixels in the periphery of CBIS to 100 pixels at 
10-pixel intervals in the vertical axis direction. For SLN, we placed 5 × 5-pixel ROIs at 
the centers of the MTLNs. 
In terms of visual evaluation, we evaluated the detectable MTLNs using MT phantom 
images created by adding the counts and noise from BG ROIs at a distance of 20 pixels 
from CBIS using ImageJ software (US National Institutes of Health, Bethesda, MD, 
USA) [19]. In this evaluation discrete, randomly displayed MTLNs were scored using a 
3-grade scale (“clear” = 2 points, “faint” = 1 point, and “unclear” = 0 point) by 11 
radiological technologists with experience in nuclear medicine techniques. 
 
Statistical analysis 
Differences in image contrast according to body type and MTLN visibility were 
analyzed using the Wilcoxon rank-sum test and McNemar’s test, respectively. The 
McNemar’s test analysis was performed for two detection samples (clear or faint) 
versus non-detection samples (unclear) from MTLNs visibility. Differences were 
considered significant at p < 0.05. 
 
Imaging of a clinical case 
On the morning of SLN biopsy, the operating surgeon injected tracer (0.3 ml, 18.5 
MBq, 99mTc-phytate) into peritumoral sites. After the surgeon massaged the area for 
approximately 5 minutes post-injection, lymphoscintigrams were acquired subsequently 
under the same conditions used for phantom imaging. 
Although this acquisition condition is unique, we have routinely obtained 
lymphoscintigrams by using this method at our institution. Our institutional ethics 
committee approved the investigation of lymphoscintigrams in accordance with the 
comprehensive prior consent in this study because the committee determined that these 
unique lymphoscintigrams were previously obtained in the routine clinical practice, not 
for the research purpose. 
 
RESULTS 
Effect of scattering emitted from the CBIS 
Figure 2 shows images and profile curves of the CB phantom obtained using the 
conventional method as well as the posterior view (LEHR) after horizontal inversion for 
subtraction process and the subtraction method. The CB phantom image acquired using 
the conventional method enlarged the surrounding background area and counts because 
of scattering emitted from CBIS, whereas the subtraction method reduced the 
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background area and counts. Therefore, with the conventional method, CBLN nearest to 
CBIS was covered by the scattering, whereas the subtraction method detected this 
CBLN. The “hot spot peak” of CBLN nearest to CBIS could even be identified from 
profile curves when the subtraction method was used. 
 
Deterioration of visibility caused by subtraction processing 
The MTLN count ratios for the subtraction method relative to the conventional 
method were 63.0%, 81.6%, and 88.5% with the leptosome, normal, and obesity models, 
respectively. Figure 3 shows images of the MT phantom obtained with the conventional 




Figure 3: Images acquired with the multi-lymph node (MT) phantom. The upper row 
shows (a) the conventional method and (b) subtraction method on a leptosome body 
type model. The middle row shows (c) the conventional method and (d) subtraction 
method on a normal body type model. The lower row shows (e) the conventional 
method and (f) subtraction method on an obesity body type model. 
 
Image contrast 
Figure 4 shows the MTLNs image contrast to radioactivity ratios based on the 
distance from CBIS and radioactivity, as determined using the conventional and 
subtraction methods. Both methods yielded negative contrast at a distance of 10 pixels 
nearest to CBIS (i.e., the scattering count from CBIS was higher than the MTLN 
counts). At 20 pixels from CBIS, the conventional method yielded negative values for 
faint MTLNs (<1/1280, approximately 12 kBq), whereas the subtraction method yielded 
positive values for all MTLNs. Overall, the contrast obtained with the subtraction 
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method improved as MTLN radioactivity and distance to CBIS decreased. The contrast 
values obtained with the subtraction method did not differ significantly between the 
body types (p > 0.05). 
 
 
Figure 4: Images acquired with the multi-lymph node (MT) phantom. The upper row 
shows (a) the conventional method and (b) subtraction method on a leptosome body 
type model. The middle row shows (c) the conventional method and (d) subtraction 
method on a normal body type model. The lower row shows (e) the conventional 
method and (f) subtraction method on an obesity body type model. 
 
Visual evaluation 
Figures 5, 6a, and 6b present images of the visual evaluation, scoring results, and 
contrast values at a distance of 20 pixels from CBIS. The faintest MTLN, with a 
radioactivity ratio of 1/5120 (approximately 3 kBq), was difficult to detect using both 
methods and visibility was not improved with the subtraction method (p = 0.16). 
However, the visibilities from 1/2560 (approximately 6 kBq) to 1/640 (approximately 
23 kBq) were significantly improved with the subtraction method (p < 0.001). At high 
levels of radioactivity (not less than 1/320), both methods could detect the MTLNs, and 




Figure 5: Visual evaluation images created using ImageJ software. We added counts 
and noise corresponding to a distance of 20 pixels from the combination phantom 
injection site (CBIS) to the multi-lymph node (MT) phantom images. The upper row 
shows (a) the conventional method and (b) subtraction method on a leptosome body 
type model. The middle row shows (c) the conventional method and (d) subtraction 
method on a normal body type model. The lower row shows (e) the conventional 
method and (f) subtraction method on an obesity body type model. 
 
 
Figure 6: (a) Results of a visual evaluation obtained from the image shown in Figure 5. 
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The horizontal axis represents the radioactivity ratios in the multi-lymph node phantom 
lymph nodes (MTLNs) relative to combination phantom injection site (CBIS) 
radioactivity (15 MBq). The vertical axis represents the mean visual evaluation values 
(“clear” = 2 points, “faint” = 1 point, and “unclear” = 0 point) scored by 11 radiological 
technologists. The statistical analysis was performed using McNemar’s test. (b) Contrast 
values at a distance of 20 pixels, corresponding to the results of the visual evaluation. 
 
Presentation of two clinical cases 
Figure 7 shows the lymphoscintigram findings of two patients with breast cancer, 
obtained using the conventional and subtraction methods. Only the subtraction method 
could detect SLNs near the tumor (Figure 7a). 
 
 
Figure 7: Lymphoscintigraphy data from patients with breast cancer. The upper row 
shows lymphoscintigram finding via (a) the conventional method and (b) subtraction 
method in a case where SLN was located near the tumor. The lower row shows 
lymphoscintigram finding via (c) the conventional method and (d) subtraction method 
in a case where SLN was located away from the tumor. 
 
DISCUSSION 
The aim of lymphoscintigraphy is to present a clear image of SLN locations to 
surgeons. Mariani et al. [4] reported that scattering increases the difficulty of SLN 
detection near a tumor. De Cicco et al. [2] reported that approximately 0.1% of the 
injected radioactivity is retained per lymph node when a tracer is injected into the 
peritumoral parenchyma. Therefore, a prime disadvantage of lymphoscintigraphy is that 
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scattering emitted from the injection site could complicate visibility and possibly cover 
SLNs. This phenomenon is especially problematic for faint and small-sized SLNs near 
injection sites. To address this problem, we devised our subtraction method. 
On CB phantom images, when we measured scattering counts from the same area as 
the CBLN nearest to CBIS in a vertical axis direction that did not contain CBLN counts, 
the conventional and the subtraction method yielded counts of 99 and 14, respectively. 
This result was obtained by reducing the area rich in scattering emitted from CBIS 
through subtraction of the posterior view from the anterior view with the subtraction 
method. On the other hand, the CBLN image counts were approximately 210 (58 kBq) 
and approximately 60 (29 kBq). Therefore, for a hot spot of 29 kBq, the subtraction 
method could detect the CBLN nearest CBIS because the CBLN counts were higher 
than the BG counts. In contrast, the conventional method could not detect the CBLN 
because the BG counts were higher. For a hot spot of 58 kBq, the CBLN counts were 
higher than the BG counts with both methods. However, visibility of the conventional 
method was reduced by low contrast because the CBLN counts are only about double 
the background counts. 
Generally, dual-head γ-camera imaging is performed using identical collimators for 
both the anterior and posterior views. In breast cancer cases evaluated using the same 
collimator, the foot of the posterior-view CBIS peak is extended by the effect of a body 
thickness span and scatter because the target (injection site) is located on the front of the 
body. When the CB phantom profile curve obtained with an identical collimator pair is 
superimposed, as shown in Figure 8d and 8g, the posterior view curve is higher than the 
anterior view at an area corresponding to scattering at the foot of the CBIS peak. If 
image was subtracted by identical collimator, subtraction at the foot of the CBIS peak 
becomes excessive. An excess following subtraction causes the periphery of CBIS to 
lack a ring shape, as shown in Figure 8f and 8i. Although the image count of the area 
becomes zero, the calculation value from actual counts becomes negative, as shown in 
Figure 8e and 8h. In the results obtained with a normal body type, the area counts had a 
maximum value of −843 when both collimators were LEGP, with CBLN counts of 
approximately 210 (58 kBq) and approximately 60 (29 kBq). Accordingly, even if the 
CBLN contains some radioactivity, all or part of the hot spot disappears on the image 
when identical collimators are used because the hot spot is offset by negative counts. 
These findings confirm that for the subtraction method, the lower collimator requires a 





Figure 8: Images and profile curves generated using differences in the combinations of 
collimators obtained on a normal body type with a combination (CB) phantom. The 
upper row shows (a) the fusion profile curves of the anterior view (solid line) and 
posterior view (dashed line), (b) the profile curve subtracted from the actual count 
values, and (c) the image generated with the subtraction method. Similarly, the middle 
row shows (d) the fusion profile curve, (e) the profile curve after subtraction from actual 
count values, and (f) the image when both collimators were low-energy general-purpose 
(LEGP). The lower row shows (g) the fusion profile curve, (h) profile curve after 
subtraction from actual count values, and (i) the image when both collimators were 
low-energy high-resolution (LEHR). 
 
Tsushima et al. [16] reported the appearance of star-shaped artifacts caused by septal 
γ-ray penetration, which could impair the visualization of SLNs located near the tumor. 
Based on this report, the routine imaging in authorial institution is using a LEGP with a 
thick septal to suppress the appearance of artifacts. Accordingly, to acquire images with 
the subtraction method, the LEHR, which has a higher resolution than the LEGP, was 
selected as the lower collimator. When the profile curves of the CB phantom obtained 
with this combination were superimposed, the curves coincided at an area 
corresponding to scattering at the foot of the CBIS peak, as shown in Figure 8a. When 
the full width at tenth maximum (FWTM) of CBIS was measured, subtraction of the 
posterior view with LEHR from the anterior view with LEGP yielded the value closest 
to zero because the respective values of the anterior and posterior view were 22.2 and 
32.0 mm on LEHR images and 24.4 and 39.0 mm on the LEGP images. These results 
indicated that subtracting the posterior view from the anterior view eliminated only an 
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area rich in scattering, and thus the subtraction method could detect SLNs near injection 
site and covered by scattering. 
Furthermore, the subtraction method demonstrated that SLNs do not disappear during 
subtraction because the MTLNs counts were retained to a level of at least 63.0 %, 
compared with the conventional method. Two factors might explain this result. The first 
factor was caused by a difference in sensitivity between the LEGP and LEHR 
collimators. When the MTLN counts for the anterior views were compared between 
collimators, the LEGP had an approximately 1.6-fold higher sensitivity than the LEHR. 
A second factor was caused on the basis of a distance-related attenuation difference 
between the detectors and a photon absorption difference related to passage through the 
human body in the anterior and posterior views. As the lymph nodes near the injection 
site affecting visibility are located at the side of the upper detector (anterior view), the 
MTLN count of posterior view will be lower than the anterior view because of 
attenuation and absorption. Even in subtracted images, the MTLN will retain detectable 
radioactivity because of the difference in counts caused by these factors. 
Image contrast was improved with the subtraction method, except for MTLNs located 
at a distance of 10 pixels, as the radioactivity and distance to CBIS decreased. Detection 
of MTLNs at a distance of 10 pixels was not improved by the subtraction method 
because the system resolution of the γ-camera could not distinguish the effect of direct 
radiation at the injection site itself from scattering. In addition, MTLNs located far from 
the injection site or those with counts considerably higher than the background were not 
affected by scattering and thus did not benefit from the subtraction method. 
In a visual evaluation of MTLNs at a distance of 20 pixels, a significant difference in 
detection was observed from 1/2560 to 1/640. There was no significant difference in the 
visual evaluation of MTLNs with ratios of 1/320 or higher because the conventional 
method could detect these counts that were considerably higher than the scattering 
counts. In contrast, neither method could detect the faintest MTLNs (1/5120), which 
had very low counts. 
Contrast values of no less than 0.44 in the conventional method and no less than 0.75 
in the subtraction method were capable of detecting MTLNs, according to the visual 
evaluation results. The detectable contrast value increased with the subtraction method 
because the visual stimulation yielded by the subtraction method became weak at 
overall counts lower than those required for the conventional method at equal levels of 
image contrast. 
In the phantom study, the subtraction method was shown to be useful for the 
detection of faint SLNs near the injection site, regardless of body type.  
In breast cancer, axillary lymph nodes are considered the most important area for 
lymphoscintigraphy. However, injection into the C region nearest axillary lymph nodes 
is most affected by scattering. As breast cancers arise most frequently in the C region, it 
is very important to improve SLN visibility in that region by reducing the effect of 
scattering. 
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Previous studies reported similar results. For example, several papers [8-12] reported 
that modifying the imaging position improved the accuracy of SLN detection. As these 
methods increased the distance between the C region and axilla by modifying the 
imaging position, scattering from the injection site could be avoided. In addition, other 
methods, including incorporation of a lead shield [7], changes in the acquisition energy 
window [18], and collimators [14-16], were reported in several papers. These methods 
were performed with the intent to directly reduce scattering at the injection site. 
Although any of these methods could enhance SLN visibility by reducing the effect of 
scattering, these methods required additional imaging to achieve this aim. Additional 
imaging has the disadvantage of placing burdens on routine workers and patients. 
In contrast to these previously reported methods, the subtraction method requires no 
additional imaging and is thus advantageous. Furthermore, the subtraction method can 
be easily used in the absence of special devices, as only the posterior view is subtracted. 
Generally, lymphoscintigraphy imaging does not require the posterior view; acquisition 
of only the anterior view is considered sufficient because the target in breast cancer 
cases is located on the front of the body. Even if the posterior view is acquired via 
simultaneous imaging with a lower detector, this is simply done according to imaging 
protocol habits. Our facility has acquired simultaneously lymphoscintigrams as routine 
imaging using a dual-head camera since before this study. A new idea came to us that it 
utilizes posterior view for elimination of scattering through routine work. We focused 
on the utilization of this posterior view for the subtraction method. 
Another advantage of the subtraction method is its ability to present conventional 
method images at identical positions, as the imaging protocols are conducted 
simultaneously. Therefore, if a surgeon requested to see both the subtraction and 
conventional method images, the subtraction method could satisfy this request because 
it can advantageously present both images. 
Lastly, although the results from the subtraction method yielded improved SLN 
visibility, as shown in Figure 7a and 7b, this is only true for SLNs near the injection site. 
One disadvantage of the subtraction method is the weak visual stimulation due to count 
reduction, which causes a deterioration in the SLN visibility not affected by scattering 
(i.e., distal from the injection site), as shown in Figure 7d relative to Figure 7c. For this 
reason, we recommend the presentation of both images, even if surgeons request to 
view only one type of image. This disadvantage of the subtraction method can be 
overcome by presenting both images. 
 
CONCLUSIONS 
The subtraction method yielded improved SLN visibility near the injection site 
through a quantitative evaluation of phantom images. Using the subtraction method, 
both subtraction and conventional images can be acquired simultaneously in a single 
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